The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pronomz Ventures LLP
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Pronomz Ventures LLP, part of the promoter and promoter group of Solara Active Pharma Sciences, purchased 20,00,000 equity shares (4.16%) through the open market on June 16, 2025. Before the purchase, the promoter group's collective holding stood at 1,82,31,281 shares (37.94%), and after the acquisition it rose to 2,02,31,281 shares (42.10%). The disclosure is filed under Regulation 29(2) of SEBI Takeover Regulations, which covers acquisitions in the 2%–5% creeping band. The acquisition was funded and executed entirely by Pronomz Ventures LLP, while other promoter group entities' holdings remained unchanged.
This is a confidence-boosting signal as the promoter group is increasing its stake in Solara from open market purchases, taking total holding to 42.10%. Despite the increased stake, promoter holding remains below the 50% mark, so this is a creeping acquisition close to the 5% incremental trigger threshold and may be followed by further disclosures if buying continues.